GDNF and amyotrophic lateral sclerosis: In addition, there are other treatments that combine stem cells with neurotrophic factors, such as glial-derived neurotrophic factors (GDNFs) and vascular endothelial growth factor (VEGF), to target the NMJ and muscle atrophy in an ALS animal model [64,65].